Curcumin blocks chronic morphine analgesic tolerance and brain-derived neurotrophic factor upregulation

NeuroReport

Volumn 20, Issue 1, 2009, Pages 63-68

  Matsushita, Yosuke ^a   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Addiction; Analgesia; Brain derived neurotrophic factor; Curcumin; Epigenetic

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR ANTIBODY IMMUNOGLOBULIN G; CURCUMIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MORPHINE; NALOXONE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EPIGENETICS; EXON; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

ANALGESICS, OPIOID; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CURCUMIN; DRUG TOLERANCE; ENZYME INHIBITORS; EXONS; HOT TEMPERATURE; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED C57BL; MORPHINE; PHYSICAL STIMULATION; REACTION TIME; REFLEX; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 58149214046     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328314decb     Document Type: Article

References (25)

1. Ueda H, Inoue M, Mizuno K. New approaches to study the development of morphine tolerance and dependence. Life Sci 2003; 74:313-320.
2. Von Zastrow M. A cell biologist's perspective on physiological adaptation to opiate drugs. Neuropharmacology 2004; 47 (Suppl 1):286-292.
3. Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 2001; 81:299-343.
4. Ueda H. Anti-opioid systems in morphine tolerance and addiction - locus-specific involvement of nociceptin and the NMDA receptor. Novartis Found Symp 2004; 261:155-162. Discussion 162-166, 191-193.
5. Ueda H, Yamaguchi T, Tokuyama S, Inoue M, Nishi M, Takeshima H. Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci Lett 1997; 237:136-138.
6. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991; 251:85-87.
7. Mitchell JM, Basbaum AI, Fields HL. A locus and mechanism of action for associative morphine tolerance. Nat Neurosci 2000; 3:47-53.
8. Malin DH, Lake JR, Fowler DE, Hammond MV, Brown SL, Leyva JE, et al. FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides 1990; 11:277-280.
9. Berhow MT, Hiroi N, Nestler EJ. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 1996; 16:4707-4715.
10. Kozela E, Popik P. The effects of NMDA receptor antagonists on acute morphine antinociception in mice. Amino Acids 2002; 23:163-168.
11. Mendez IA, Trujillo KA. NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats. Psychopharmacology (Berl) 2008; 196:497-509.
12. Inoue M, Mishina M, Ueda H. Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J Neurosci 2003; 23:6529-6536.
13. Caldeira MV, Melo CV, Pereira DB, Carvalho RF, Carvalho AL, Duarte CB. BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol Cell Neurosci 2007; 35:208-219.
14. Takayama N, Ueda H. Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia. J Neurosci 2005; 25:430-435.
15. Berhow MT, Russell DS, Terwilliger RZ, Beitner-Johnson D, Serf DW, Lindsay RM, et al. Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 1995; 68:969-979.
16. Akbarian S, Rios M, Liu RJ, Gold SJ, Fong HF, Zeiler S, et al. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J Neurosci 2002; 22:4153-4162.
17. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16:109-110.
18. Matsumoto M, Inoue M, Hald A, Xie W, Ueda H. Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 2006; 318:735-740.
19. Barco A, Patterson S, Alarcon JM, Gromova P, Mata-Roig M, Morozov A, et al. Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture. Neuron 2005; 48:123-137.
20. Hnasko TS, Sotak BN, Palmiter RD. Morphine reward in dopamine-deficient mice. Nature 2005; 438:854-857.
21. Tortorici V, Morgan MM, Vanegas H. Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla of rats. Pain 2001; 89:237-244.
22. Balasubramanyam K, Varier RA, Altaf M, Swaminathan V, Siddappa NB, Ranga U, et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004; 279:51163-51171.
23. Carlezon WA Jr, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci 2005; 28:436-445.
24. Ai W, Gong J, Yu L. MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway. FEBS Lett 1999; 456:196-200.
25. Nemmani KV, Lalonde J, Mogil JS. Region-specific changes of calcium/calmodulin-dependent protein kinase IV in the mouse brain following chronic morphine treatment. Neuroreport 2005; 16:879-882.